Given that all three beta-blockers significantly increased HO-1 expression in this model, we may infer that carvedilol, bisoprolol and metoprolol may all act to increase endogenous antioxidant defences and thus may be of benefit in the treatment of preeclampsia. The gene discussed is HMOX1; the disease is preeclampsia.